🇺🇸 FDA
Patent

US 7700738

Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins

granted A61KA61K2039/507A61P

Quick answer

US patent 7700738 (Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins) held by The Regents of the University of California expires Mon Apr 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Apr 20 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
53
CPC classes
A61K, A61K2039/507, A61P, A61P31/04, A61P39/00